<DOC>
	<DOCNO>NCT02211105</DOCNO>
	<brief_summary>The purpose prospective observational research study registry examine whether two GERD surgery ( Laparoscopic Nissen Fundoplication ( LNF ) Transoral Incisionless Fundoplication ( TIF ) ) similar outcome effectiveness , safety , post-operative side effect post-procedure cost associate episode care ensue complication .</brief_summary>
	<brief_title>Registry Compare Two Surgical Treatments GERD</brief_title>
	<detailed_description>This registry prospectively enroll 500 patient undergoing TIF LNF approximately 20 United States center proficient procedure provide informed consent mention data collection ( symptom questionnaire , medical treatment , complication , side-effects cost ) . The observational registry obtain patient clinical data relate gastrointestinal symptom three year post-consent . At baseline three-year period follow clinically indicate TIF LNF procedure , data obtain phone call and/or office-visits make specified interval . During data collection period , patient ask complete standard validate symptom questionnaire well report episode care related procedure along financial cost care .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<criteria>GERD symptom ( heartburn , define substernal burning discomfort arise upper abdomen chest , regurgitation , define effortless arise liquid material chest mouth ) two time week ( antisecretory medication ) adversely affect patient 's quality life . Additionally , patient respond medical therapy ( adequate relief symptom ) indicate GERDHRQL regurgitation score medical therapy . In context , score â‰¤ 2 GERDHRQL regurgitation question ( medication ) indicate absence daily bothersome symptom therefore patient consider responsive medical therapy . Furthermore , patient objective evidence GERD document ( esophagitis endoscopy pathological intraesophageal acid exposure prolong ambulatory esophageal pH monitor ) . Age 1880 year Ability give inform consent Regular access telephone Meet clinical criterion treatment GERD TIF LNF undergo TIF LNF within 90 day provide consent . Dependent upon PPIs control heartburn &gt; six month patient determine inadequate response regurgitation symptom despite heartburn control PPIs Hiatal hernia axial length large 2 cm transverse dimension exceed 2.0 cm Gastroesophageal junction Hill Grade III Patient willing provide inform consent , cooperate postoperative dietary recommendation followup assessment test Objective documentation pathological acidreflux either ) increase intraesophageal acid exposure prolong ambulatory esophageal pH monitoring ( pH &lt; 4 4.5 % great time ) without impedance b ) presence erosive esophagitis ( LA Grade A B ) endoscopy Absence severe esophageal motility disorder ( note : mild abnormality esophageal motility common GERD small break , etc . ) include achalasia , esophagogastric junction outflow obstruction , frequent fail peristalsis , diffuse esophageal spasm , nutcracker jackhammer esophagus etc . highresolution esophageal manometry use Chicago classification system evidence incomplete bolus clearance 30 % swallow impedance test . Hiatal hernia &gt; 2 cm ( defined longitudinal length measure endoscopically proximal margin gastric fold diaphragmatic pinch ) Esophagitis LA Grade C D Presence troublesome atypical symptom Barrett 's esophagus great 2 cm length dysplasia Esophageal stricture severe esophageal motility disorder History previous resective gastric esophageal surgery , cervical spine fusion , Zenker 's diverticulum , esophageal epiphrenic diverticulum , achalasia , scleroderma dermatomyositis , eosinophilic esophagitis , cirrhosis uncontrolled systemic disease . Active gastroduodenal ulcer disease Gastric outlet obstruction stenosis Gastroparesis delay gastric empty confirm four hour solidphase gastric empty study Body Mass Index ( BMI ) &gt; 35 Pregnancy plan pregnancy within 12 month procedure Portal hypertension and/or varices New York Heart Association classification III IV . Coagulation disorder Intraprocedural determination anatomical presentation opinion surgeon allow safe performance procedure Enrollment another device drug study may confound result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>GastroEsophageal Reflux Disease</keyword>
	<keyword>Transoral Incisionless Fundoplication</keyword>
	<keyword>Laparoscopic Nissen Fundoplication</keyword>
</DOC>